Nateglinide

CAS : 105816-04-4

Ref. 3D-FN26165

Informations sur le produit

• Nom: Nateglinide
• Synonymes: N-[[trans-4-(1-Methylethyl)cyclohexyl]carbonyl]-D-phenylalanineA 4166AY 4166, AY 4166, N-[[trans-4-(1-Methylethyl)cyclohexyl]carbonyl]-D-phenylalanine, D-Phenylalanine, N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-, D-Phenylalanine, N-[[4-(1-methylethyl)cyclohexyl]carbonyl]-, trans-, A 4166

Description

Nateglinide is used to treat type 2 diabetes mellitus as an oral hypoglycemic, insulinotropic agent. It is a blocker of ATP-dependent potassium channels and works by increasing the body's production of insulin, which lowers blood glucose levels. Nateglinide has been shown to be effective in reducing postprandial blood glucose levels in patients with type 2 diabetes who have not responded well to other treatments. The effects of nateglinide are reversible.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 317.42 g/mol
• Formule: C₁₉H₂₇NO₃
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder
• InChI: InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15?,16?,17-/m1/s1
• Code InChI: InChIKey=OELFLUMRDSZNSF-OFLPRAFFSA-N
• SMILES: CC(C)C1CCC(C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1